Patents by Inventor Blas COLL CRESPO

Blas COLL CRESPO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for improving lipid profiles using atrasentan
    Patent number: 9855245
    Abstract: The present disclosure is directed to methods for reducing cardiovascular risk in a human subject by administering atrasentan, or a pharmaceutically acceptable salt thereof, in an amount sufficient to effect a reduction of about 5% or more in one or both of (a) total serum cholesterol, relative to the subject's baseline total serum cholesterol, and (b) serum LDL cholesterol, relative to the subject's baseline serum LDL cholesterol.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: January 2, 2018
    Assignee: AbbVie Inc.
    Inventors: Blas Coll Crespo, Dennis Andress, John J. Brennan, James C. Stolzenbach
  • METHODS FOR IMPROVING LIPID PROFILES USING ATRASENTAN
    Publication number: 20160074363
    Abstract: The present disclosure is directed to methods for reducing cardiovascular risk in a human subject by administering atrasentan, or a pharmaceutically acceptable salt thereof, in an amount sufficient to effect a reduction of about 5% or more in one or both of (a) total serum cholesterol, relative to the subject's baseline total serum cholesterol, and (b) serum LDL cholesterol, relative to the subject's baseline serum LDL cholesterol.
    Type: Application
    Filed: April 30, 2014
    Publication date: March 17, 2016
    Applicant: Abbvie Inc.
    Inventors: Blas COLL CRESPO, Dennis ANDRESS, Peter J. BRENNAN, James C. STOLZENBACH